IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CORVO', RENZO GIACINTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 728
EU - Europa 270
AS - Asia 141
OC - Oceania 2
SA - Sud America 2
Totale 1.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 726
UA - Ucraina 62
CN - Cina 61
DE - Germania 53
IT - Italia 31
FI - Finlandia 30
PL - Polonia 28
SG - Singapore 28
HK - Hong Kong 26
GB - Regno Unito 18
TR - Turchia 16
IE - Irlanda 14
CZ - Repubblica Ceca 9
RU - Federazione Russa 7
FR - Francia 6
VN - Vietnam 6
SE - Svezia 5
BE - Belgio 3
AU - Australia 2
CA - Canada 2
ID - Indonesia 2
AL - Albania 1
AR - Argentina 1
BR - Brasile 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
SI - Slovenia 1
Totale 1.143
Salva come PNG Salva come JPEG
Città #
Fairfield 109
Ashburn 72
Houston 56
Woodbridge 56
Jacksonville 49
Wilmington 49
Cambridge 48
Chandler 44
Seattle 44
Helsinki 29
Princeton 28
Warsaw 28
Ann Arbor 27
Hong Kong 26
Singapore 26
New York 18
Beijing 14
Dublin 14
Istanbul 12
Nanjing 10
Brescia 8
Brno 8
Jinan 8
San Diego 8
Shanghai 8
Changsha 7
Des Moines 7
Dearborn 6
Dong Ket 6
Falls Church 4
Kocaeli 4
London 4
Munich 4
Brussels 3
Los Angeles 3
Boardman 2
Ceto 2
Haikou 2
Hangzhou 2
Hebei 2
Jakarta 2
Nanchang 2
Ningbo 2
Nürnberg 2
Pisa 2
San Francisco 2
Washington 2
Acton 1
Anzio 1
Athens 1
Buenos Aires 1
Cambados 1
Canberra 1
Chicago 1
Chiswick 1
Frankfurt am Main 1
Hefei 1
Hounslow 1
Kunming 1
Ljubljana 1
Melbourne 1
Naples 1
Newark 1
North York 1
Norwalk 1
Olomouc 1
Orange 1
Petah Tikva 1
Philadelphia 1
Redwood City 1
Rende 1
Santa Clara 1
Shenyang 1
São Paulo 1
Tianjin 1
Tirana 1
Toronto 1
Wandsworth 1
Westminster 1
Totale 903
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 150
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 141
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 131
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 116
GUROPA survey: genito-urinary radiation oncology prescription attitudes 92
Applying radiation protection and safety in radiotherapy 80
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 79
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 77
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 70
COVID-19 outbreak and cancer radiotherapy disruption in italy: Survey endorsed by the italian association of radiotherapy and clinical oncology (AIRO) 53
Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak 51
Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group 50
Letter to the Editor 49
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 34
Totale 1.173
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020199 0 0 0 0 14 28 27 27 21 39 24 19
2020/2021314 16 18 29 35 27 26 8 38 25 47 24 21
2021/2022125 13 7 4 9 2 9 3 15 3 17 8 35
2022/2023111 15 7 12 8 6 23 1 10 20 1 4 4
2023/2024156 10 3 23 15 8 29 3 5 28 3 2 27
2024/202554 0 1 0 38 15 0 0 0 0 0 0 0
Totale 1.173